Presenting Author: Sumaira Mubarik – PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy, University of Groningen, 9713 AV Groningen, The Netherlands
### @@@ Xuechun Li – PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy, University of Groningen, 9713 AV Groningen, The Netherlands ### 2641736###Co-Author######PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy, University of Groningen, 9713 AV Groningen, The Netherlands###Co-Author: Xuechun Li – PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy, University of Groningen, 9713 AV Groningen, The Netherlands
### @@@ Eelko Hak – PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy, University of Groningen, 9713 AV Groningen, The Netherlands ### 2641737###Co-Author######PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy, University of Groningen, 9713 AV Groningen, The Netherlands###Co-Author: Eelko Hak – PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy, University of Groningen, 9713 AV Groningen, The Netherlands
### 2F-01Co-Author: Jigar Bandaria, PhD – OM1, Inc.
### @@@ Michelle B. Leavy, MPH – OM1 ### 2642859###Presenting Author######OM1###Presenting Author: Michelle B. Leavy, MPH – OM1
### @@@ Costas Boussios, PhD – OM1, Inc. ### 2642860###Co-Author######OM1, Inc.###Co-Author: Costas Boussios, PhD – OM1, Inc.
### 4D-02Presenting Author: Anna Booman – Stanford University School of Medicine
### @@@ Sara Siadat – Stanford University School of Medicine ### 2642867###Co-Author######Stanford University School of Medicine###Co-Author: Sara Siadat – Stanford University School of Medicine
### @@@ Brian Bateman – Stanford University School of Medicine ### 2641812###Co-Author######Stanford University School of Medicine###Co-Author: Brian Bateman – Stanford University School of Medicine
### @@@ Irogue Igbinosa – Stanford University School of Medicine ### 2642868###Co-Author######Stanford University School of Medicine###Co-Author: Irogue Igbinosa – Stanford University School of Medicine
### @@@ Elliott Main – Stanford University School of Medicine ### 2642869###Co-Author######Stanford University School of Medicine###Co-Author: Elliott Main – Stanford University School of Medicine
### @@@ Deirdre Lyell – Stanford University School of Medicine ### 2642870###Co-Author######Stanford University School of Medicine###Co-Author: Deirdre Lyell – Stanford University School of Medicine
### @@@ Cecilia Leggett – Stanford University School of Medicine ### 2642871###Co-Author######Stanford University School of Medicine###Co-Author: Cecilia Leggett – Stanford University School of Medicine
### @@@ Stephanie Leonard – Stanford University School of Medicine ### 2642872###Co-Author######Stanford University School of Medicine###Co-Author: Stephanie Leonard – Stanford University School of Medicine
### 1F-03Presenting Author: BaoTrang Le, PharmD, MSc – Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, Florida, USA
### @@@ Yehua Wang, MSPH – Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, Florida, USA ### 2642630###Co-Author###PhD student###Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, Florida, USA###Co-Author: Yehua Wang, MSPH – Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, Florida, USA
### @@@ Yanning Wang, MS – College of Pharmacy, University of Florida, Gainesville, Florida, USA ### 2642631###Co-Author###Data Scientist, PhD student###College of Pharmacy, University of Florida, Gainesville, Florida, USA###Co-Author: Yanning Wang, MS – College of Pharmacy, University of Florida, Gainesville, Florida, USA
### @@@ Nicole E. Smolinski, PharmD, PhD – Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, Florida, USA ### 2642632###Co-Author###Research Assistant Professor###Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, Florida, USA###Co-Author: Nicole E. Smolinski, PharmD, PhD – Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, Florida, USA
### @@@ Judith C. Maro – Harvard Medical School & Harvard Pilgrim Health Care Institute ### 2641582###Co-Author###Associate Professor###Harvard Medical School & Harvard Pilgrim Health Care Institute###Co-Author: Judith C. Maro – Harvard Medical School & Harvard Pilgrim Health Care Institute
### @@@ Almut G. Winterstein, PharmD, PhD – Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, Florida, USA ### 2642633###Co-Author###Distinguished Professor, Director For CoDES, Director For Consortium For Medical Marijuana Clinical###Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, Florida, USA###Co-Author: Almut G. Winterstein, PharmD, PhD – Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, Florida, USA
### 6B-05